Apogee Therapeutics, Inc.
APGE
Revenue
0.00
0.000.00%
-Assets
937.13M
▲310.98M▲49.66%
3 Months ChangeLiabilities
33.25M
▼-6.57M▼-16.50%
3 Months ChangeFree Cash Flow
-52.79M
▼-20.81M▼-65.05%
12 Months ChangeRevenue/Cost Of Revenue
Loading...
Net Profit/Loss
Loading...
Assets/Liabilities
Loading...
Cash Flows
Loading...
Loading...
Loading...
Recent Quarterly and Annual Filings
2026-03-02
Form 8-K
ID: 0001974640-26-000001
2026-01-06
Form 8-K
ID: 0001104659-26-001063
2025-11-10
Form 10-Q
ID: 0001193125-25-273260
2025-11-10
Form 8-K
ID: 0001193125-25-273250
2025-10-10
Form 8-K
ID: 0001104659-25-098487
2025-08-11
Form 10-Q
ID: 0000950170-25-106234
2025-08-11
Form 8-K
ID: 0000950170-25-106228
2025-07-07
Form 8-K
ID: 0001104659-25-065926
2025-06-23
Form 8-K
ID: 0000950170-25-088600
2025-05-12
Form 10-Q
ID: 0000950170-25-068513